Goldstream Capital Management LTD Surface Oncology, Inc. Transaction History

Goldstream Capital Management LTD

  • $297 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$2.65 - $5.08 $639,405 - $1.23 Million
-241,285 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$4.73 - $7.9 $1.14 Million - $1.91 Million
241,285 New
241,285 $1.15 Million

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Goldstream Capital Management LTD Portfolio

Follow Goldstream Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldstream Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Goldstream Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email